Transplant vs bortezomib and LEN/DEX in multiple myeloma

Transplant vs bortezomib and LEN/DEX in multiple myeloma

Isatuximab + Len/Dex/Bortezomib vs IsaRd in Newly Diagnosed Transplant Ineligible Multiple MyelomaПодробнее

Isatuximab + Len/Dex/Bortezomib vs IsaRd in Newly Diagnosed Transplant Ineligible Multiple Myeloma

Bortezomib dosing for Multiple MyelomaПодробнее

Bortezomib dosing for Multiple Myeloma

ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3Подробнее

ASH 2023 Multiple Myeloma Highlights – PERSEUS, IsKia, Bortezomib dosing, KarMMA-3

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer InstituteПодробнее

Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute

2019 Multiple Myeloma Symposium | Novel and Next Generation TherapyПодробнее

2019 Multiple Myeloma Symposium | Novel and Next Generation Therapy